Seaport Therapeutics, Inc. (SPTX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-03) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-06-08) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | — |
|
| Statements | ||
| Condensed Consolidated Balance Sheets (unaudited) | — |
|
| Condensed Consolidated Balance Sheets (unaudited) (P) | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) (P) | — |
|
| Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (deficit) (unaudited) | — |
|
| Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (unaudited) | — |
|
| Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (deficit) (unaudited) (P) | — |
|
| Condensed Consolidated Statements of Cash Flows (unaudited) | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | — |
|
| Commitments and Contingencies | — |
|
| Common Stock | — |
|
| Convertible Preferred Stock | — |
|
| Fair Value Measurements | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | — |
|
| Investments | — |
|
| Leases | — |
|
| License and Collaboration Agreements | — |
|
| Nature of Business and Basis of Presentation | — |
|
| Net Loss Per Share | — |
|
| Pay Vs Performance Disclosure | — |
|
| Prepaid Expenses and Other Current Assets | — |
|
| Property and Equipment, Net | — |
|
| Related Parties | — |
|
| Segments | — |
|
| Stock-based Compensation | — |
|
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | — |
|